Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis
GLP-1 & GIP therapy targets GLP-1 and glucagon receptors on pancreatic beta cells, boosting insulin release
2 Currently, the only GLP-1 receptor agonists licensed for weight management are Saxenda, Wegovy and Mounjaro
Cleveland Clinic, Muscle Atrophy. Accessed April 6, 2025
GLP-1 plays a role in appetite regulation, digestion, and blood sugar balance
By offering judgment-free support, grounded information, and tools for behavior change, you help ensure that any decisionwhether to pursue medication or notis rooted in long-term well-being, not quick fixes